User menu

Stromal architecture and periductal decorin are potential prognostic markers for ipsilateral locoregional recurrence in ductal carcinoma in situ of the breast

Bibliographic reference Van Bockstal, Mieke ; Lambein, Kathleen ; Gevaert, Olivier ; De Wever, Olivier ; Praet, Marleen ; et. al. Stromal architecture and periductal decorin are potential prognostic markers for ipsilateral locoregional recurrence in ductal carcinoma in situ of the breast. In: Histopathology, Vol. 63, no.4, p. n/a-n/a (2013)
Permanent URL http://hdl.handle.net/2078/187554
  1. Pinder Sarah E, Ductal carcinoma in situ (DCIS): pathological features, differential diagnosis, prognostic factors and specimen evaluation, 10.1038/modpathol.2010.40
  2. ROSNER DUTZU, BEDWANI RAMEZ N., VANA JOSEF, BAKER HARVEY W., MURPHY GERALD P., Noninvasive Breast Carcinoma : Results of a National Survey by the American College of Surgeons, 10.1097/00000658-198008000-00001
  3. Glover J. A., Bannon F. J., Hughes C. M., Cantwell M. M., Comber H., Gavin A., Deady S., Murray L. J., Increased diagnosis and detection rates of carcinoma in situ of the breast, 10.1007/s10549-012-1975-y
  4. Wapnir I. L., Dignam J. J., Fisher B., Mamounas E. P., Anderson S. J., Julian T. B., Land S. R., Margolese R. G., Swain S. M., Costantino J. P., Wolmark N., Long-Term Outcomes of Invasive Ipsilateral Breast Tumor Recurrences After Lumpectomy in NSABP B-17 and B-24 Randomized Clinical Trials for DCIS, 10.1093/jnci/djr027
  5. Silverstein Melvin J, The University of Southern California/Van Nuys prognostic index for ductal carcinoma in situ of the breast, 10.1016/s0002-9610(03)00265-4
  6. Rudloff Udo, Jacks Lindsay M., Goldberg Jessica I., Wynveen Christine A., Brogi Edi, Patil Sujata, Van Zee Kimberly J., Nomogram for Predicting the Risk of Local Recurrence After Breast-Conserving Surgery for Ductal Carcinoma In Situ, 10.1200/jco.2009.26.8847
  7. Han K., Nofech-Mozes S., Narod S., Hanna W., Vesprini D., Saskin R., Taylor C., Kong I., Paszat L., Rakovitch E., Expression of HER2neu in Ductal Carcinoma in situ is Associated with Local Recurrence, 10.1016/j.clon.2011.09.008
  8. Altintas Sevilay, Lambein Kathleen, Huizing Manon T., Braems Geert, Asjoe Fernando Tjin, Hellemans Hilde, Van Marck Eric, Weyler Joost, Praet Marleen, Van den Broecke Rudy, Vermorken Jan B., Tjalma Wiebren A., Prognostic Significance of Oncogenic Markers in Ductal Carcinoma In Situ of the Breast: A Clinicopathologic Study, 10.1111/j.1524-4741.2009.00686.x
  9. Holmes Phoebe, Lloyd Joshua, Chervoneva Inna, Pequinot Edward, Cornfield Dennis B., Schwartz Gordon F., Allen Kathleen G., Palazzo Juan P., Prognostic markers and long-term outcomes in ductal carcinoma in situ of the breast treated with excision alone, 10.1002/cncr.25942
  10. Kerlikowske K., Molinaro A. M., Gauthier M. L., Berman H. K., Waldman F., Bennington J., Sanchez H., Jimenez C., Stewart K., Chew K., Ljung B. M., Tlsty T. D., Biomarker Expression and Risk of Subsequent Tumors After Initial Ductal Carcinoma In Situ Diagnosis, 10.1093/jnci/djq101
  11. Witkiewicz Agnieszka K., Dasgupta Abhijit, Nguyen Katherine, Liu Chengbao, Kovatich Albert J., Schwartz Gordon F., Pestell Richard G., Sotgia Federica, Rui Hallgeir, Lisanti Michael P., Stromal caveolin-1 levels predict early DCIS progression to invasive breast cancer, 10.4161/cbt.8.11.8874
  12. Yi Min, Meric-Bernstam Funda, Kuerer Henry M., Mittendorf Elizabeth A., Bedrosian Isabelle, Lucci Anthony, Hwang Rosa F., Crow Jaime R., Luo Sheng, Hunt Kelly K., Evaluation of a Breast Cancer Nomogram for Predicting Risk of Ipsilateral Breast Tumor Recurrences in Patients With Ductal Carcinoma in Situ After Local Excision, 10.1200/jco.2011.36.4976
  13. Provenzano E, Hopper J.L, Giles G.G, Marr G, Venter D.J, Armes J.E, Biological markers that predict clinical recurrence in ductal carcinoma in situ of the breast, 10.1016/s0959-8049(02)00666-4
  14. Denys Hannelore, Braems Geert, Lambein Kathleen, Pauwels Patrick, Hendrix An, De Boeck Astrid, Mathieu Veronique, Bracke Marc, De Wever Olivier, The Extracellular Matrix Regulates Cancer Progression and Therapy Response: Implications for Prognosis and Treatment, 10.2174/138161209787846711
  15. De Wever Olivier, Demetter Pieter, Mareel Marc, Bracke Marc, Stromal myofibroblasts are drivers of invasive cancer growth, 10.1002/ijc.23925
  16. Rudnick Jenny A., Kuperwasser Charlotte, Stromal biomarkers in breast cancer development and progression, 10.1007/s10585-012-9499-8
  17. Yazhou Cui, Wenlv Shen, Weidong Zhang, Licun Wu, Clinicopathological Significance of Stromal Myofibroblasts in Invasive Ductal Carcinoma of the Breast, 10.1159/000081394
  18. Pavlakis Kitty, Messini Irene, Vrekoussis Thomas, Yiannou Petros, Keramopoullos Dimitrios, Louvrou Niki, Liakakos Theodoros, Stathopoulos Efstathios N, The assessment of angiogenesis and fibroblastic stromagenesis in hyperplastic and pre-invasive breast lesions, 10.1186/1471-2407-8-88
  19. Barth Peter J., Ebrahimsade Schokufe, Ramaswamy Annette, Moll Roland, CD34+ fibrocytes in invasive ductal carcinoma, ductal carcinoma in situ, and benign breast lesions, 10.1007/s004280100530
  20. Witkiewicz Agnieszka K., Freydin Boris, Chervoneva Inna, Potoczek Magdalena, Rizzo Wendy, Rui Hallgeir, Brody Jonathan R., Schwartz Gordon F., Lisanti Michael P., Stromal CD10 and SPARC expression in ductal carcinoma in situ (DCIS) patients predicts disease recurrence, 10.4161/cbt.10.4.12449
  21. Fisher Edwin R., Land Stephanie R., Saad Reda S., Fisher Bernard, Wickerham D. Lawrence, Wang Meihua, Costantino Joseph P., Wolmark Norman, Pathologic Variables Predictive of Breast Events in Patients With Ductal Carcinoma In Situ, 10.1309/wh9la543nr76y29j
  22. Pinder S E, Duggan C, Ellis I O, Cuzick J, Forbes J F, Bishop H, Fentiman I S, George W D, A new pathological system for grading DCIS with improved prediction of local recurrence: results from the UKCCCR/ANZ DCIS trial, 10.1038/sj.bjc.6605718
  23. Cornfield Dennis B., Palazzo Juan P., Schwartz Gordon F., Goonewardene Shanth A., Kovatich Albert J., Chervoneva Inna, Hyslop Terry, Schwarting Roland, The prognostic significance of multiple morphologic features and biologic markers in ductal carcinoma in situ of the breast : A study of a large cohort of patients treated with surgery alone, 10.1002/cncr.20260
  24. Gevaert Olivier, Daemen Anneleen, De Moor Bart, Libbrecht Louis, A taxonomy of epithelial human cancer and their metastases, 10.1186/1755-8794-2-69
  25. Pinder, World Health Organization classification of tumours, 95 (2012)
  26. Wernicke Mario, Piñeiro Laura Cecilia, Caramutti Daniela, Dorn Vanesa G., Raffo Maria Marta Lopez, Guixa Hector G., Telenta Margarita, Morandi Ana Alcestes, Breast Cancer Stromal Myxoid Changes Are Associated with Tumor Invasion and Metastasis: A Central Role for Hyaluronan, 10.1097/01.mp.0000051582.75890.2d
  27. Lambein K., Praet M., Forsyth R., Van den Broecke R., Braems G., Matthys B., Cocquyt V., Denys H., Pauwels P., Libbrecht L., Relationship between pathological features, HER2 protein expression and HER2 and CEP17 copy number in breast cancer: biological and methodological considerations, 10.1136/jcp.2010.084863
  28. Wolff, Arch. Pathol. Lab. Med., 131, 18 (2007)
  29. Allred D. C., Clark G. M., Elledge R., Fuqua S. A. W., Brown R. W., Chamness G. C., Osborne C. K., McGuire W. L., Association of p53 Protein Expression With Tumor Cell Proliferation Rate and Clinical Outcome in Node-Negative Breast Cancer, 10.1093/jnci/85.3.200
  30. Hammond, Arch. Pathol. Lab. Med., 134, E48 (2010)
  31. Sloan Erica K., Ciocca Daniel R., Pouliot Normand, Natoli Anthony, Restall Christina, Henderson Michael A., Fanelli Mariel A., Cuello-Carrión Fernando D., Gago Francisco E., Anderson Robin L., Stromal Cell Expression of Caveolin-1 Predicts Outcome in Breast Cancer, 10.2353/ajpath.2009.080924
  32. Simpkins Samantha A, Hanby Andrew M, Holliday Deborah L, Speirs Valerie, Clinical and functional significance of loss of caveolin-1 expression in breast cancer-associated fibroblasts, 10.1002/path.4034
  33. Leygue Etienne, Snell Linda, Dotzlaw Helmut, Troup Sandra, Hiller-Hitchcock Tamara, Murphy Leigh C., Roughley Peter J., Watson Peter H., Lumican and decorin are differentially expressed in human breast carcinoma, 10.1002/1096-9896(200011)192:3<313::aid-path694>3.0.co;2-b
  34. Allred D. Craig, Anderson Stewart J., Paik Soonmyung, Wickerham D. Lawrence, Nagtegaal Iris D., Swain Sandra M., Mamounas Elefetherios P., Julian Thomas B., Geyer Charles E., Costantino Joseph P., Land Stephanie R., Wolmark Norman, Adjuvant Tamoxifen Reduces Subsequent Breast Cancer in Women With Estrogen Receptor–Positive Ductal Carcinoma in Situ: A Study Based on NSABP Protocol B-24, 10.1200/jco.2010.34.0141
  35. Millar Ewan K. A., Tran Kayla, Marr Penny, Graham Peter H., p27KIP-1cyclin A and cyclin D1 protein expression in ductal carcinoma in situ of the breast: p27KIP-1correlates with hormone receptor status but not with local recurrence, 10.1111/j.1440-1827.2007.02079.x
  36. Knudsen Erik S., Pajak Thomas F., Qeenan Maria, McClendon A. Kathleen, Armon Benjamin D., Schwartz Gordon F., Witkiewicz Agnieszka K., Retinoblastoma and Phosphate and Tensin Homolog Tumor Suppressors: Impact on Ductal Carcinoma In Situ Progression, 10.1093/jnci/djs446
  37. Wernicke, Medicina (Buenos Aires), 71, 15 (2011)
  38. Savage Kay, Leung Samuel, Todd S. Katrina, Brown Lindsay A., Jones Robin L., Robertson David, James Michelle, Parry Suzanne, Rodrigues Pinilla S. Maria, Huntsman David, Reis-Filho Jorge S., Distribution and significance of caveolin 2 expression in normal breast and invasive breast cancer: an immunofluorescence and immunohistochemical analysis, 10.1007/s10549-007-9718-1
  39. Danielson Keith G., Baribault Helene, Holmes David F., Graham Helen, Kadler Karl E., Iozzo Renato V., Targeted Disruption of Decorin Leads to Abnormal Collagen Fibril Morphology and Skin Fragility, 10.1083/jcb.136.3.729
  40. Hallberg Gunilla, Andersson Eva, Naessen Tord, Ekman-Ordeberg Gunvor, The expression of syndecan-1, syndecan-4 and decorin in healthy human breast tissue during the menstrual cycle, 10.1186/1477-7827-8-35
  41. Boström Pia, Sainio Annele, Kakko Tanja, Savontaus Mikko, Söderström Mirva, Järveläinen Hannu, Localization of decorin gene expression in normal human breast tissue and in benign and malignant tumors of the human breast, 10.1007/s00418-012-1026-0
  42. Goldoni Silvia, Seidler Daniela G., Heath Jack, Fassan Matteo, Baffa Raffaele, Thakur Mathew L., Owens Rick T., McQuillan David J., Iozzo Renato V., An Antimetastatic Role for Decorin in Breast Cancer, 10.2353/ajpath.2008.080275
  43. Santra Manoranjan, Eichstetter Inge, Iozzo Renato V., An Anti-oncogenic Role for Decorin : DOWN-REGULATION OF ErbB2 LEADS TO GROWTH SUPPRESSION AND CYTODIFFERENTIATION OF MAMMARY CARCINOMA CELLS, 10.1074/jbc.m006821200
  44. Troup, Clin. Cancer Res., 9, 207 (2003)